USIDNET: A strategy to build a community of clinical immunologists

Journal of Clinical Immunology

Volumn 34, Issue 4, 2014, Pages 428-435

  Sullivan, Kathleen E ^a   Puck, Jennifer M ^b   Notarangelo, Luigi D ^c   Fuleihan, Ramsay ^d   Caulder, Tara ^e   Wang, Connie ^e   Boyle, Marcia ^e   Cunningham Rundles, Charlotte ^f  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e Immune Deficiency Foundation   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

comparative effectiveness; immunoglobulin; Primary immune deficiency; registry

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; CELL LINE; COMPARATIVE EFFECTIVENESS; DEMOGRAPHY; DISEASE REGISTRY; HEALTH PROGRAM; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGIST; MEDICAL INFORMATION; PATIENT CARE; PATIENT INFORMATION; PILOT STUDY; PRIORITY JOURNAL; UNITED STATES IMMUNE DEFICIENCY NETWORK; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; IMMUNOLOGY; MALE; MEDICAL EDUCATION; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PERSONNEL MANAGEMENT; PHYSICIAN; REGISTER; SUPPLY AND DISTRIBUTION;

COMMON VARIABLE IMMUNODEFICIENCY; EDUCATION, MEDICAL, CONTINUING; FEMALE; HUMANS; MALE; PHYSICIANS; PILOT PROJECTS; REGISTRIES; STAFF DEVELOPMENT;

EID: 84901432019     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-014-0028-1     Document Type: Article

References (26)

1. Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine. 2000;79:155-69. (Pubitemid 30327530)
2. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. N Engl J Med. 1991;324(8):509-16.
3. Gallin JI, Alling DW, Malech HL,Wesley R, Koziol D,Marciano B, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med. 2003;348(24):2416-22. (Pubitemid 36682820)
4. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997;131(1 Pt 1):47-54. (Pubitemid 27498308)
5. Guzman D, Veit D, Knerr V, Kindle G, Gathmann B, Eades-Perner AM, et al. The ESID Online Database network. Bioinformatics. 2007;23(5):654-5. (Pubitemid 46522608)
6. IshimuraM, Takada H, Doi T, Imai K, Sasahara Y, Kanegane H, et al. Nationwide survey of patients with primary immunodeficiency diseases in Japan. J Clin Immunol. 2011;31(6):968-76.
7. Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. 2007;27(5):517-24. (Pubitemid 47319258)
8. Nozaki T, Takada H, Ishimura M, Ihara K, Imai K, Morio T, et al. Endocrine complications in primary immunodeficiency diseases in Japan. Clin Endocrinol. 2012;77(4):628-34.
9. Mir Saeid Ghazi B, Aghamohammadi A, Kouhi A, Farhoudi A, Moin M, Rezaei N, et al. Mortality in primary immunodeficient patients, registered in Iranian primary immunodeficiency registry. Iran J Allergy Asthma Immunol. 2004;3(1):31-6.
10. Aghamohammadi A, Moein M, Farhoudi A, Pourpak Z, Rezaei N, Abolmaali K, et al. Primary immunodeficiency in Iran: first report of the National Registry of PID in Children and Adults. J Clin Immunol. 2002;22(6):375-80. (Pubitemid 35305887)
11. Shah BR, Drozda J, Peterson ED. Leveraging observational registries to inform comparative effectiveness research. Am Heart J. 2010;160(1):8-15.
12. Frobert O, Lagerqvist B, Olivecrona GK, Omerovic E, Gudnason T, Maeng M, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369(17):1587-97.
13. Pollard C, Bailey KA, Petitte T, Baus A, Swim M, Hendryx M. Electronic patient registries improve diabetes care and clinical outcomes in rural community health centers. J Rural Health Off J Am Rural Health Assoc Natl Rural Health Care Assoc. 2009;25(1):77-84.
14. Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, et al. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation. 2010;122(6):585-96.
15. Holmes JA, Carpenter WR, Wu Y, Hendrix LH, Peacock S, Massing M, et al. Impact of distance to a urologist on early diagnosis of prostate cancer among black and white patients. J Urol. 2012;187(3):883-8.
16. Rogler LE, Kosmyna B, Moskowitz D, Bebawee R, Rahimzadeh J, Kutchko K, et al. Small RNAs derived from lncRNA RNase MRP have gene-silencing activity relevant to human cartilage-hair hypoplasia. Hum Mol Genet. 2014;23(2):368-82.
17. Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2011;2:54.
18. Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside. J Clin Immunol. 2013;33(6):1078-87.
19. Teutsch SM, Fielding JE. Comparative effectiveness - looking under the lamppost. JAMA. 2011;305(21):2225-6.
20. Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111(1):77-85.
21. Rakhmanov M, Keller B, Gutenberger S, Foerster C, Hoenig M, Driessen G, et al. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci U S A. 2009;106(32):13451-6.
22. Kappelman MD, Crandall WV, Colletti RB, Goudie A, Leibowitz IH, Duffy L, et al. Short pediatric Crohn's disease activity index for quality improvement and observational research. Inflamm Bowel Dis. 2011;17(1):112-7.
23. Crandall WV, Margolis PA, Kappelman MD, King EC, Pratt JM, Boyle BM, et al. Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease. Pediatrics. 2012;129(4):e1030-41.
24. Tuchman L, Schwartz M. Health outcomes associated with transition from pediatric to adult cystic fibrosis care. Pediatrics. 2013;132(5):847-53.
25. Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27(5):497-502. (Pubitemid 47319256)
26. Modell V, Gee B, Lewis DB, Orange JS, Roifman CM, Routes JM, et al. Global study of primary immunodeficiency diseases (PI) - diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res. 2011;51(1):61-70.